OTCMKTS:CLABD Core One Labs - CLABD Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Core One Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. 4.35 -0.15 (-3.44%) (As of 08/13/2021) Add Compare Share Share Today's Range4.25▼4.6050-Day Range0.49▼0.7752-Week Range2.00▼5.00Volume27,000 shsAverage Volume48,295 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsHeadlinesShort Interest About Core One Labs (OTCMKTS:CLABD) StockCore One Labs, Inc. is a biotechnology company, which engages in the manufacture of cannabis-infused strips. Its focus is to bring psychedelic medicines to market through novel delivery systems and psychotherapy. The firm offers isogenics, cultivation, extraction and distillation, consulting, cannastrips, and quality and control. The company was founded on September 14, 2010 and is headquartered in Vancouver, Canada.Read More Receive CLABD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core One Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address CLABD Stock News HeadlinesNovember 18, 2022 | benzinga.comCore One Labs' Prepares for Commercial Production of API-Grade Psilocybin; Plans Initial Production Run at GMP Facility in JanuaryNovember 12, 2022 | seekingalpha.comCore Laboratories: Likely To Take A Pause, Patience!February 2, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.October 14, 2022 | investing.comCore One Labs Inc (COOL)October 7, 2022 | benzinga.comCore One Labs Nearing GMP Production as Canada's Province of Alberta Announces Game Changing LegislationSeptember 15, 2022 | finance.yahoo.comItem 9 Labs Set To Transform Arizona Marijuana Market With New Line of Infused Pre-RollsSeptember 1, 2022 | benzinga.comCore One Rolls Out Commercial Sales Strategy for its Revolutionary API Grade Biosynthetic PsilocybinAugust 16, 2022 | seekingalpha.comItem 9 Labs Corp. (INLB) CEO Andrew Bowden on Q3 2022 Results - Earnings Call TranscriptFebruary 2, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.August 16, 2022 | seekingalpha.comBlend Labs, Inc. (BLND) CEO Nima Ghamsari on Q2 2022 Results - Earnings Call TranscriptAugust 12, 2022 | apnews.comCore One Labs’ Subsidiaries Successfully Produce Psilocin Precursor for Production to PsilocybinJuly 24, 2022 | abcnews.go.comChina launches one of 2 lab modules to join space stationJuly 13, 2022 | finance.yahoo.comLooking Glass Labs to Mint and Airdrop GenZeroes NFT Card Packs with Redeemable UtilityJune 27, 2022 | finance.yahoo.com1 Day Laboratory Inspection and Auditing Online Training CourseMay 25, 2022 | markets.businessinsider.comCode Ocean Announces $16.5 Million in Series-B Funding to Expand Its Digital Lab Platform for Computational ScientistsJanuary 20, 2022 | nz.finance.yahoo.comBeyond Van Gogh: The Immersive Experience Coming Soon to AnchorageOctober 27, 2021 | seekingalpha.comCLABFAugust 13, 2021 | finance.yahoo.comCore One Labs’ Clinics Submit Application to Treat Patient With Psilocybin Psychedelic-Assisted TherapyAugust 6, 2021 | barrons.comCore One Labs Inc.August 4, 2021 | finance.yahoo.comCore One Labs’ Akome Seeks to Revolutionize Treatment of Parkinson’s Disease and Submits Application to Protect IPAugust 4, 2021 | finance.yahoo.comCore One’s Dr. Robert E.W. Hancock to Host Virtual Townhall Webcast and Present on Proprietary Biosynthesized Psilocybin Wednesday, August 4, 2021See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CLABD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core One Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Agricultural Commodities & Milling Sub-IndustryN/A SectorIndustrials Current SymbolOTCMKTS:CLABD CUSIPN/A CIKN/A Webwww.lifestyledeliverysystems.com Phone(866) 347-5058FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesJoel ShackerChief Executive Officer & DirectorGeoffrey BaldersonChief Financial Officer & SecretaryJohn David SandersonDirector & Chief Science OfficerSantiago FerroChief Medical OfficerPhil GuratHead-Investor RelationsKey CompetitorsAcreageOTCMKTS:ACRZFCosta GroupOTCMKTS:CTTQFFirst ResourcesOTC:FTROFIOI Co. BerhadOTCMKTS:IOIOFLowell FarmsOTCMKTS:LOWLFView All Competitors CLABD Stock - Frequently Asked Questions How have CLABD shares performed in 2023? Core One Labs' stock was trading at 0.50 at the start of the year. Since then, CLABD shares have increased by 775.6% and is now trading at 4.35. View the best growth stocks for 2023 here. What is Core One Labs' stock symbol? Core One Labs trades on the OTCMKTS under the ticker symbol "CLABD." How do I buy shares of Core One Labs? Shares of CLABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Core One Labs' stock price today? One share of CLABD stock can currently be purchased for approximately 4.35. How can I contact Core One Labs? Core One Labs' mailing address is 1130 West Pender Street, Vancouver, BC V6E. The official website for the company is www.lifestyledeliverysystems.com. The company can be reached via phone at (866) 347-5058. This page (OTCMKTS:CLABD) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.